#VisualAbstract: Psilocybin can reduce depressive symptoms in patients with treatment-resistant depression

byKeerthana Pasumarthi

November 18, 2022

in StudyGraphics

Reading Time: 1 min read

Pressure support ventilation does not improve ventilation status as compared to T-piece ventilation

RelatedReports

AI Roundup

2MM: AI Roundup – Roche and NVIDIA’s AI drug discovery factory and surgical robotics foundation model, Amazon’s nationwide health AI expansion, and Brown’s AI therapy ethics warning [March 2026]

April 6, 2026

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Chronic Disease

Psilocybin in combination with cognitive behavioural therapy may improve smoking abstinence compared to nicotine patches

March 16, 2026

Primary care physicians play substantial role in pediatric mental health

Cardiology

Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy

February 27, 2026

Prenatal antidepressant exposure may increase risk of poor motor development

Chronic Disease

Prenatal depression and gestational diabetes are associated with increased risk of childhood obesity

February 23, 2026

Delays in surgical intervention do not increase odds of appendiceal perforation

Association of quality and technology with patient mobility for colorectal cancer surgery

Novel coronavirus identified from patients with pneumonia in Wuhan, China

2 Minute Medicine Rewind November 21, 2022

Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]

Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.